Three pillars of post-pandemic launch excellenceIQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity Share XThree pillars of post-pandemic launch excellencehttps://pharmaphorum.com/views-and-analysis/three-pillars-of-post-pandemic-launch-excellence/
Unlocking health data to improve oncology outcomesAs the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial Share XUnlocking health data to improve oncology outcomeshttps://pharmaphorum.com/r-d/views-analysis-r-d/unlocking-health-data-to-improve-oncology-outcomes-2/
Enabling new models of care: pursuing pharma’s partnership potentialThere is a huge, ongoing shift in how health and wellness is approached in the UK, and the Share XEnabling new models of care: pursuing pharma’s partnership potentialhttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/enabling-new-models-of-care-pursuing-pharmas-partnership-potential/
Nine for 2021: The COVID-19 legacyIn the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that Share XNine for 2021: The COVID-19 legacyhttps://pharmaphorum.com/views-and-analysis/nine-for-2021-the-covid-19-legacy/
UK initiative aims to cut COVID-19 drug development to a few weeksA new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 Share XUK initiative aims to cut COVID-19 drug development to a few weekshttps://pharmaphorum.com/news/uk-initiative-aims-to-cut-covid-19-drug-development-to-a-few-weeks/
Unlocking health data to improve oncology outcomesThe NHS’ globally unique health data ecosystem has the potential to improve health outcomes. With around 363,000 new Share XUnlocking health data to improve oncology outcomeshttps://pharmaphorum.com/oncology/unlocking-health-data-to-improve-oncology-outcomes/
COVID-19 patient registry could inform lockdown exit strategyRecruitment for a patient registry app for COVID-19 is underway, which could help governments find their way out Share XCOVID-19 patient registry could inform lockdown exit strategyhttps://pharmaphorum.com/news/covid-19-patient-registry-aims-to-h/
An innovative approach to improving research and patient care with NHS dataUnderstanding how patients are treated in routine clinical care has great potential to improve treatment and enrich academic Share XAn innovative approach to improving research and patient care with NHS datahttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/improving-research-patient-care-nhs-data-iqvia/
Demonstrating the value of RWEA new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional Share XDemonstrating the value of RWEhttps://pharmaphorum.com/views-analysis-oncology/demonstrating-the-value-of-rwe/
